RAYLANE LTD

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +7.9%

  £12,804,638 → £13,810,263

• Cash

  -43.1%

  £1,214,174 → £690,710

• Net assets

  -2.9%

  £2,676,324 → £2,600,038

  lowest in 4 filed years

• Employees

  +10.3%

  87 → 96

  highest in 4 filed years

• Operating profit

  -64.5%

  £295,051 → £104,631

• Profit before tax

  -57.4%

  £212,541 → £90,628

• Wages

  +10.8%

  £1,589,737 → £1,762,025

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Hazlewoods LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“After reviewing the group's forecast projections the directors have reasonable expectation that the group has adequate resources to continue in operation for the foreseeable future. The group therefore continues to adopt the going concern basis in preparing its financial statements.”

Group structure

1. RAYLANE LTD · parent
   1. Gary Barber Pharmacies Limited 100% · UK · dispensing chemist
   2. DSP (UK) Limited 100% · UK · dispensing chemist
   3. Medilink Pharma Limited 51% · UK · dispensing chemist
   4. PM Hawkes Limited 51% · UK · dormant company
   5. SJ & JW Evans Limited 51% · UK · dormant company

Significant events

• “On 1 April 2025 the trade, assets and liabilities in relation to the subsidiary company Gary Barber Pharmacies Limited and on 1 July 2025 the trade, assets and liabilities in relation to the subsidiary company DSP (UK) Limited were hived up in to Raylane Limited as a part of the process to simplify the structure.”
• “On 30 September 2024, Medilink Pharma Limited acquired 100% of the issued share capital of PM Hawkes Limited, obtaining control. PM Hawkes Limited was hived up immediately after being acquired, and the branch contributed £812,491 revenue and £83,847 to the groups profit for the period between the date of acquisition and the balance sheet date.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

14

last 12 months

Capital events

2

last 24 months

Officers appointed

2

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.